BNGO
Price
$1.13
Change
+$0.05 (+4.67%)
Updated
Aug 3, 11:01 AM (EDT)
Capitalization
12.28M
7 days until earnings call
Intraday BUY SELL Signals
ICCM
Price
$2.89
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Capitalization
9.9M
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNGO vs ICCM

BNGO vs ICCM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BNGO vs. ICCM commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and ICCM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (BNGO: $1.07 vs. ICCM: $2.89)
Brand notoriety: BNGO and ICCM are both not notable
BNGO represents the Pharmaceuticals: Other, while ICCM is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BNGO: 157% vs. ICCM: 1%
Market capitalization -- BNGO: $12.28M vs. ICCM: $9.9M
BNGO [@Pharmaceuticals: Other] is valued at $12.28M. ICCM’s [@Medical/Nursing Services] market capitalization is $9.9M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $124.82B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $182.9B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.1B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green whileICCM’s FA Score has 1 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • ICCM’s FA Score: 1 green, 4 red.
According to our system of comparison, both BNGO and ICCM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 2 TA indicator(s) are bullish while ICCM’s TA Score has 4 bullish TA indicator(s).

  • BNGO’s TA Score: 2 bullish, 6 bearish.
  • ICCM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ICCM is a better buy in the short-term than BNGO.

Price Growth

BNGO (@Pharmaceuticals: Other) experienced а -3.60% price change this week, while ICCM (@Medical/Nursing Services) price change was -6.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.97%. For the same industry, the average monthly price growth was +1.38%, and the average quarterly price growth was +3.25%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.50%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -17.67%.

Reported Earning Dates

BNGO is expected to report earnings on Aug 10, 2026.

ICCM is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+4.97% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNGO($12.3M) has a higher market cap than ICCM($9.9M). BNGO YTD gains are higher at: -30.065 vs. ICCM (-84.210). ICCM has higher annual earnings (EBITDA): -15.41M vs. BNGO (-21.63M). BNGO has more cash in the bank: 14.4M vs. ICCM (8.12M). ICCM has less debt than BNGO: ICCM (139K) vs BNGO (17M). BNGO has higher revenues than ICCM: BNGO (28.7M) vs ICCM (3.57M).
BNGOICCMBNGO / ICCM
Capitalization12.3M9.9M124%
EBITDA-21.63M-15.41M140%
Gain YTD-30.065-84.21036%
P/E Ratio0.00N/A-
Revenue28.7M3.57M805%
Total Cash14.4M8.12M177%
Total Debt17M139K12,230%
FUNDAMENTALS RATINGS
BNGO vs ICCM: Fundamental Ratings
BNGO
ICCM
OUTLOOK RATING
1..100
8250
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
7696
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (23) in the Biotechnology industry is in the same range as ICCM (26) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ICCM (100) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

BNGO's SMR Rating (99) in the Biotechnology industry is in the same range as ICCM (100) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

BNGO's Price Growth Rating (76) in the Biotechnology industry is in the same range as ICCM (96) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

BNGO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ICCM (100) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGOICCM
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
75%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BNGO
Daily Signal:
Gain/Loss:
ICCM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LSH0.280.03
+12.87%
Lakeside Holding Limited
AMPY3.910.16
+4.27%
Amplify Energy Corp
FLOC20.450.72
+3.65%
Flowco Holdings Inc
BIDU111.113.63
+3.38%
Baidu
CVCO547.03-15.37
-2.73%
Cavco Industries

ICCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCM has been closely correlated with SINT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICCM jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCM
1D Price
Change %
ICCM100%
N/A
SINT - ICCM
67%
Closely correlated
+10.39%
ILMN - ICCM
31%
Poorly correlated
+0.00%
PEN - ICCM
31%
Poorly correlated
+0.43%
BRKR - ICCM
29%
Poorly correlated
-2.33%
BNGO - ICCM
29%
Poorly correlated
+0.94%
More